STERIS plc

STERIS plc ( STE ) Q2 2027 Earnings Call November 5, 2026 9:00 AM EST Company Participants Julie Winter - Vice President of Investor Relations & Corporate Communications Karen Burton - Senior VP, CFO & Chief Accounting Officer Daniel Carestio - President, CEO & Director Conference Call Participants Brett Fishbin - KeyBanc Capital Markets Inc., Research Division Patrick Andrew Wood - UBS Investment Bank, Research Division Steven Etoch - Stephens Inc., Research Division Michael Polark - Wolfe Research, LLC Michael Matson - Needham & Company, LLC, Research Division Jason Bednar - Piper Sandler & Co., Research Division Presentation Operator Good day, and welcome to the STERIS plc Second Quarter 2027 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.

STERIS beats Q2 fiscal 2027 earnings and revenue estimates, fueled by strong segment growth and margin gains, and raises its full-year adjusted EPS outlook.

Although the revenue and EPS for Steris (STE) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Steris (STE) came out with quarterly earnings of $2.94 per share, beating the Zacks Consensus Estimate of $2.67 per share. This compares to earnings of $2.47 per share a year ago.